-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on BioNTech, Lowers Price Target to $140

Benzinga·05/06/2026 13:28:25
Listen to the news
Wells Fargo analyst Mohit Bansal maintains BioNTech (NASDAQ:BNTX) with a Overweight and lowers the price target from $150 to $140.